Lido Advisors LLC Invests $351,000 in The Cooper Companies, Inc. (NYSE:COO)

Lido Advisors LLC purchased a new position in The Cooper Companies, Inc. (NYSE:COO) in the second quarter, Holdings Channel.com reports. The firm purchased 914 shares of the medical device company’s stock, valued at approximately $351,000.

A number of other large investors have also recently made changes to their positions in the stock. Vanguard Group Inc. grew its stake in shares of Cooper Companies by 1.3% in the first quarter. Vanguard Group Inc. now owns 5,368,727 shares of the medical device company’s stock worth $2,241,927,000 after acquiring an additional 70,640 shares during the period. BlackRock Inc. grew its stake in shares of Cooper Companies by 10.9% in the first quarter. BlackRock Inc. now owns 4,225,167 shares of the medical device company’s stock worth $1,577,508,000 after acquiring an additional 416,807 shares during the period. Veritas Asset Management LLP grew its stake in shares of Cooper Companies by 9.1% in the second quarter. Veritas Asset Management LLP now owns 2,278,069 shares of the medical device company’s stock worth $873,480,000 after acquiring an additional 189,308 shares during the period. State Street Corp grew its stake in shares of Cooper Companies by 0.5% in the first quarter. State Street Corp now owns 2,177,872 shares of the medical device company’s stock worth $909,458,000 after acquiring an additional 10,373 shares during the period. Finally, Kayne Anderson Rudnick Investment Management LLC grew its stake in shares of Cooper Companies by 1.7% in the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,531,670 shares of the medical device company’s stock worth $571,864,000 after acquiring an additional 25,335 shares during the period. 96.31% of the stock is currently owned by institutional investors.

Cooper Companies Trading Down 1.0 %

COO stock opened at $337.12 on Monday. The company has a quick ratio of 0.99, a current ratio of 1.72 and a debt-to-equity ratio of 0.33. The Cooper Companies, Inc. has a twelve month low of $302.88 and a twelve month high of $399.62. The stock has a market capitalization of $16.70 billion, a price-to-earnings ratio of 60.96, a price-to-earnings-growth ratio of 2.69 and a beta of 0.94. The firm’s fifty day simple moving average is $325.99 and its two-hundred day simple moving average is $358.79.

Cooper Companies (NYSE:COO) last posted its quarterly earnings data on Wednesday, August 30th. The medical device company reported $3.35 earnings per share for the quarter, beating analysts’ consensus estimates of $3.34 by $0.01. Cooper Companies had a net margin of 7.83% and a return on equity of 8.17%. The business had revenue of $930.20 million for the quarter, compared to analysts’ expectations of $899.77 million. During the same quarter in the previous year, the business posted $3.19 earnings per share. The business’s revenue was up 10.3% compared to the same quarter last year. As a group, analysts anticipate that The Cooper Companies, Inc. will post 12.81 earnings per share for the current year.

Analysts Set New Price Targets

COO has been the subject of several recent research reports. StockNews.com initiated coverage on shares of Cooper Companies in a research report on Thursday, October 5th. They set a “hold” rating for the company. Citigroup lowered their target price on shares of Cooper Companies from $440.00 to $420.00 in a report on Monday, October 2nd. Morgan Stanley started coverage on shares of Cooper Companies in a report on Thursday, September 28th. They issued an “equal weight” rating and a $410.00 target price on the stock. Bank of America started coverage on shares of Cooper Companies in a report on Monday, October 30th. They issued a “buy” rating and a $380.00 target price on the stock. Finally, Mizuho reissued a “buy” rating and issued a $440.00 target price on shares of Cooper Companies in a report on Monday, August 28th. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, Cooper Companies presently has a consensus rating of “Moderate Buy” and a consensus target price of $401.30.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.